Try our beta test site

Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01424436
First received: August 4, 2011
Last updated: January 27, 2017
Last verified: January 2017